Holen Sie sich die Stockscreener-App
7.53
1.21%
0.09
Handel nachbörslich:
7.53
Schlusskurs vom Vortag:
$7.44
Offen:
$7.39
24-Stunden-Volumen:
238.88K
Relative Volume:
0.72
Marktkapitalisierung:
$198.13M
Einnahmen:
$56.65M
Nettoeinkommen (Verlust:
$-53.31M
KGV:
-3.6836
EPS:
-2.0442
Netto-Cashflow:
$-40.75M
1W Leistung:
-8.73%
1M Leistung:
+52.12%
6M Leistung:
-4.32%
1J Leistung:
-31.86%
1-Tages-Spanne:
$7.10
$7.95
1-Wochen-Bereich:
$7.10
$8.22
52-Wochen-Spanne:
$4.2993
$13.34
Cvrx Inc Stock (CVRX) Company Profile
Firmenname
Cvrx Inc
Sektor
Branche
Telefon
(763) 416-2850
Adresse
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
Compare CVRX vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVRX
Cvrx Inc
|
7.53 | 195.76M | 56.65M | -53.31M | -40.75M | -2.0442 |
|
ABT
Abbott Laboratories
|
108.03 | 187.91B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
336.77 | 129.05B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.14 | 112.19B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.13 | 101.72B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
81.81 | 49.14B | 6.07B | 1.06B | 1.34B | 1.8063 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-01-14 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-09-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-07-11 | Bestätigt | Lake Street | Buy |
| 2024-05-01 | Fortgesetzt | Craig Hallum | Buy |
| 2024-05-01 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-05-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-01-31 | Eingeleitet | Lake Street | Buy |
| 2022-07-18 | Eingeleitet | Craig Hallum | Buy |
| 2021-07-26 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-26 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-26 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Cvrx Inc Aktie (CVRX) Neueste Nachrichten
CVRx enables first Barostim implant at Baptist Medical Center expanding heart failure treatment options - Traders Union
Buybacks Report: Does CVRx Inc meet Warren Buffetts criteria2026 PreEarnings & Precise Buy Zone Tips - baoquankhu1.vn
Energy Moves: Why is CVRx Inc stock going downMarket Sentiment Review & Smart Allocation Stock Reports - baoquankhu1.vn
CVRx shares rise on CMS inclusion for Barostim implant procedure - MSN
Quarterly Earnings: Is CVRx Inc. stock affected by interest rate hikesTrade Risk Summary & High Return Stock Watch Alerts - Naître et grandir
CVRx, Inc. (NASDAQ:CVRX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
How Cvrx Inc. (CVRX) Affects Rotational Strategy Timing - Stock Traders Daily
Risk Check: Whats the beta of CVRx Inc stock2025 Macro Impact & Weekly High Return Stock Forecasts - baoquankhu1.vn
Barostim device transforms life after severe heart failure, CVRx asserts - Traders Union
Trend Recap: Why is CVRx Inc stock going downPortfolio Return Summary & Safe Capital Growth Trade Ideas - baoquankhu1.vn
CVRx to present late-breaking THT2026 data in clinical webinar - Traders Union
CVRx Introduces New Performance-Based Executive Stock Unit Plan - The Globe and Mail
CVRx (CVRX) lists Chief HR Officer Gregory Morrison as insider on Form 3 - Stock Titan
CVRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
CVRx approves performance stock units tied to 2026-2027 revenue goals - Investing.com Nigeria
CVRx (NASDAQ: CVRX) CFO gets major option, RSU grants and tax sale - Stock Titan
CVRx (CVRX) CEO Kevin Hykes gets major equity grants, sells shares for taxes - Stock Titan
CVRx (NASDAQ: CVRX) officer receives major equity grants, sells shares to cover taxes - Stock Titan
CVRx (NASDAQ: CVRX) CRO gets new stock awards, sells shares for taxes - Stock Titan
COO of CVRx (NASDAQ: CVRX) receives 23,000 options and 15,000 shares - Stock Titan
CVRx (NASDAQ: CVRX) grants revenue-linked PSUs to executives - Stock Titan
CVRX,INVA Dividends - Finviz
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc.CVRX - FinancialContent
SGP,CVRX Earnings - Finviz
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
CVRx opens THT2026 with new scientific data on Barostim outcomes - Traders Union
Heart failure device Barostim tested in 400 patients, data due at THT 2026 - Stock Titan
SGP,CVRX Short Interest - Finviz
CVRX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
CVRx partners with Orlando Health South Lake Hospital for first Barostim implant - Traders Union
CVRx unveils new Barostim research at THT2026 satellite program - Traders Union
IMA,CVRX Latest SEC Filings - Finviz
Smart Money: Should you buy the dip on CVRx IncJuly 2025 Momentum & Low Volatility Stock Suggestions - baoquankhu1.vn
CVRx celebrates milestone with 101st Barostim implant - Traders Union
CVRXCvrx, Inc. Latest Stock News & Market Updates - Stock Titan
Market Catalysts: What is the earnings history of CVRx IncWeekly Market Report & Low Risk Profit Maximizing Plans - baoquankhu1.vn
(CVRX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
$CVRX stock is up 9% today. Here's what we see in our data. - Quiver Quantitative
Monday 2/23 Insider Buying Report: MPLT, CVRX - Nasdaq
Craig-Hallum Maintains CVRx Inc(CVRX.US) With Buy Rating - 富途牛牛
CVRx (NASDAQ:CVRX) Director Buys $297,648.00 in Stock - MarketBeat
CVRx director Jain Mudit K. buys $297k in shares By Investing.com - Investing.com India
CVRx director Jain Mudit K. buys $297k in shares - Investing.com Australia
Insider Purchase: Director at $CVRX Buys 46,800 Shares - Quiver Quantitative
CVRx : Statement of Changes in Beneficial Ownership (Form 4) - marketscreener.com
Director-linked Treo Ventures buys 46,800 CVRx (CVRX) shares - Stock Titan
Bank Watch: Is CVRX stock heavily shorted2025 Macro Impact & Weekly Return Optimization Plans - baoquankhu1.vn
Earnings call transcript: CVRx Q4 2025 sees stock surge despite earnings miss - Investing.com Nigeria
CVRx hosts Advanced Practice Providers Summit in Nashville - Traders Union
Landmark Heart Failure Trial Begins - Medical Product Outsourcing
Securities Fraud Investigation Into CVRx, Inc. (CVRX) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz - The AI Journal
Finanzdaten der Cvrx Inc-Aktie (CVRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cvrx Inc-Aktie (CVRX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER |
Mar 02 '26 |
Sale |
7.90 |
1,284 |
10,146 |
60,551 |
| OASHEIM JARED | CHIEF FINANCIAL OFFICER |
Mar 02 '26 |
Sale |
7.90 |
1,744 |
13,781 |
96,703 |
| John Robert Allen | Chief Revenue Officer |
Mar 02 '26 |
Sale |
7.90 |
3,964 |
31,326 |
86,036 |
| Jain Mudit K. | Director |
Feb 20 '26 |
Buy |
6.36 |
46,800 |
297,592 |
980,183 |
| Jain Mudit K. | Director |
Feb 18 '26 |
Buy |
4.64 |
600 |
2,785 |
5,650 |
| JOHNSON & JOHNSON | 10% Owner |
Nov 26 '25 |
Sale |
10.03 |
6,337 |
63,560 |
4,040,861 |
| JOHNSON & JOHNSON | 10% Owner |
Nov 24 '25 |
Sale |
10.06 |
2,200 |
22,132 |
4,047,198 |
| JOHNSON & JOHNSON | 10% Owner |
Nov 21 '25 |
Sale |
10.00 |
500 |
5,000 |
4,049,398 |
| JOHNSON & JOHNSON | 10% Owner |
Nov 12 '25 |
Sale |
10.00 |
1,000 |
10,000 |
4,049,898 |
| JOHNSON & JOHNSON | 10% Owner |
Nov 06 '25 |
Sale |
10.21 |
52,332 |
534,310 |
4,051,098 |
0.66%
1.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):